The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Alzheimer's disease in Down syndrome: Neurobiology and risk
Abstract
Down syndrome (DS) is characterized by increased mortality rates, both during early and later stages of life, and age‐specific mortality risk remains higher in adults with DS compared with the overall population of people with mental retardation and with typically developing populations. Causes of increased mortality rates early in life are primarily due to the increased incidence of congenital heart disease and leukemia, while causes of higher mortality rates later in life may be due to a number of factors, two of which are an increased risk for Alzheimer's disease (AD) and an apparent tendency toward premature aging. In this article, we describe the increase in lifespan for people with DS that has occurred over the past 100 years, as well as advances in the understanding of the occurrence of AD in adults with DS. Aspects of the neurobiology of AD, including the role of amyloid, oxidative stress, Cu/ZN dismutase (SOD‐1), as well as advances in neuroimaging are presented. The function of risk factors in the observed heterogeneity in the expression of AD dementia in adults with DS, as well as the need for sensitive and specific biomarkers of the clinical and pathological progressing of AD in adults with DS is considered. © 2007 Wiley‐Liss, Inc. MRDD Research Reviews 2007;13:237–246.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268
Rovelet-Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249
Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome
Wisniewski, K. E., Wisniewski, H. M., & Wen, G. Y. (1985) · Annals of Neurology · doi:10.1002/ana.410170310 · Cited by 1,159
Oxidative damage in Alzheimer's
Smith, M. A., Perry, G., Richey, P. L., Sayrec, L. M., Anderson, V. E., Beal, M. F., & Kowall, N. (1996) · Nature · doi:10.1038/382120b0 · Cited by 894
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study
Yang, Q., Rasmussen, S. A., & Friedman, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08092-3 · Cited by 847
The Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842
Cognitive Reserve and Alzheimer Disease
Stern, Y. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213815.20177.19 · Cited by 838
(1959) · PubMed · Cited by 820
Effects of Race and Income on Mortality and Use of Services among Medicare Beneficiaries
Gornick, M. E., Eggers, P. W., Reilly, T. W., Mentnech, R. M., Fitterman, L. K., Kucken, L. E., & Vladeck, B. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351106 · Cited by 808
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Adams and Victor’s Principles of Neurology
Lanska, D. J. (2010) · JAMA · doi:10.1001/jama.2010.396 · Cited by 745
Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741
Snowdon, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530310034029 · Cited by 696
Fundamentals of Genetic Epidemiology
Khoury, M. J., Beaty, T. H., & Cohen, B. H. (1993) · doi:10.1093/oso/9780195052886.001.0001 · Cited by 696
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Baldereschi, M., Brayne, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1992 · Cited by 650
Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.685 · Cited by 643
Adams and Victor's Principles of Neurology
Ropper, A. H., & Samuels, M. A. (1997) · Cited by 636
Observations on an Ethnic Classification of Idiots
Down, J. L. H. (1867) · Journal of Mental Science · doi:10.1192/bjp.13.61.121 · Cited by 587
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561
Organization of the entorhinal—hippocampal system: A review of current anatomical data
Witter, M. P. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030707 · Cited by 533
Apolipoprotein E, Dementia, and Cortical Deposition of β-Amyloid Protein
Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinistö, L., Halonen, P., & Kontula, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331902 · Cited by 493
The four ages of Down syndrome
Bittles, A. H., Bower, C., Hussain, R., & Glasson, E. J. (2007) · The European Journal of Public Health · doi:10.1093/eurpub/ckl103 · Cited by 492
The changing survival profile of people with Down's syndrome: implications for genetic counselling
Glasson, E., Sullivan, S., Hussain, R., Petterson, B., Montgomery, P., & Bittles, A. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620506.x · Cited by 475
Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
Plasticity of Hippocampal Circuitry in Alzheimer's Disease
Geddes, J. W., Monaghan, D. T., Cotman, C. W., Lott, I. T., Kim, R. C., & Chui, H. C. (1985) · Science · doi:10.1126/science.4071042 · Cited by 461
Self-citationPlasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
van Oijen, M., Hofman, A., Soares, H. D., Koudstaal, P. J., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70501-4 · Cited by 458
Development of dementing illnesses in an 80‐year‐old volunteer cohort
Katzman, R., Aronson, M., Fuld, P., Kawas, C., Brown, T., Morgenstern, H., Frishman, W., Gidez, L., Eder, H., & Ooi, W. L. (1989) · Annals of Neurology · doi:10.1002/ana.410250402 · Cited by 452
The Influence of Intellectual Disability on Life Expectancy
Bittles, A. H., Petterson, B. A., Sullivan, S. G., Hussain, R., Glasson, E. J., & Montgomery, P. D. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.m470 · Cited by 450
Plasma Aβ40 and Aβ42 and Alzheimer’s disease: Relation to age, mortality, and risk
Mayeux, R., Honig, L. S., Tang, M.-X., Manly, J., Stern, Y., Schupf, N., & Mehta, P. D. (2003) · Neurology · doi:10.1212/01.wnl.0000091890.32140.8f · Cited by 434
The apolipoprotein ε4 allele in patients with Alzheimer's disease
Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340527 · Cited by 414
Molecular mapping of alzheimer‐type dementia in Down's syndrome
Prasher, V. P., Farrer, M. J., Kessling, A. M., Fisher, E. M. C., West, R. J., Barber, P. C., & Butler, A. C. (1998) · Annals of Neurology · doi:10.1002/ana.410430316 · Cited by 414
Telomere shortening in T cells correlates with Alzheimer's disease status
Panossian, L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00043-x · Cited by 411
The neuroanatomy of general intelligence: sex matters
Haier, R. J., Jung, R. E., Yeo, R. A., Head, K., & Alkire, M. T. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.11.019 · Cited by 387
Education and Alzheimer disease without dementia: Support for the cognitive reserve hypothesis
Roe, C. M., Xiong, C., Miller, J. P., & Morris, J. C. (2007) · Neurology · doi:10.1212/01.wnl.0000251303.50459.8a · Cited by 347
Is the Risk of Developing Alzheimer's Disease Greater for Women than for Men?
Hebert, L. E., Scherr, P. A., McCann, J. J., Beckett, L. A., & Evans, D. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.2.132 · Cited by 331
Elroy-Stein, O., Bernstein, Y., & Groner, Y. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04255.x · Cited by 316
Macleod, K., Leprince, D., & Stehelin, D. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90404-w · Cited by 304
Riley, K. P., Snowdon, D. A., Desrosiers, M. F., & Markesbery, W. R. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.019 · Cited by 303
Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome
Holland, A. J., Hon, J., Huppert, F. A., Stevens, F., & Watson, P. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.6.493 · Cited by 288
Cognitive Decline and Literacy Among Ethnically Diverse Elders
Manly, J. J., Schupf, N., Tang, M.-X., & Stern, Y. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281868 · Cited by 283
Trends in the Black-White Life Expectancy Gap in the United States, 1983-2003
Harper, S., Lynch, J., Burris, S., & Davey Smith, G. (2007) · JAMA · doi:10.1001/jama.297.11.1224 · Cited by 278
Childhood mental ability and dementia
Whalley, L. J., Starr, J. M., Athawes, R., Hunter, D., Pattie, A., & Deary, I. J. (2000) · Neurology · doi:10.1212/wnl.55.10.1455 · Cited by 274
Alzheimer's disease: Genetic aspects and associated clinical disorders
Heyman, A., E, W. E., Hurwitz, B. J., Schmechel, D., Sigmon, A. H., Weinberg, T., Helms, M. J., & Swift, M. (1983) · Annals of Neurology · doi:10.1002/ana.410140503 · Cited by 272
Robakis, N., Wisniewski, H., Jenkins, E., Devine-Gage, E., Houck, G., Yao, X.-L., Ramakrishna, N., Wolfe, G., Silverman, W., & Ted Brown, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91754-5 · Cited by 268
Holland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2000.00263.x · Cited by 259
Korenberg, J. R., Kawashima, H., Pulst, S. M., Ikeuchi, T., Ogasawara, N., Yamamoto, K., Schonberg, S. A., West, R. J., Allen, L., & Magenis, E. (1990) · PubMed · Cited by 242
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
Yaffe, K., Lui, L.-Y., Grady, D., Cauley, J., Kramer, J., & Cummings, S. R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02628-3 · Cited by 242
EARLY SENILE DEMENTIA IN MONGOLOID IDIOCY
JERVIS, G. A. (1948) · American Journal of Psychiatry · doi:10.1176/ajp.105.2.102 · Cited by 227
Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Oown's syndrome fetal brain
Brooksbank, B. W. L., & Balazs, R. (1984) · Developmental Brain Research · doi:10.1016/0165-3806(84)90060-9 · Cited by 225
Henderson, V. W. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.017 · Cited by 216
Leverenz, J. B., & Raskind, M. A. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6777 · Cited by 214
Alzheimer disease and Down syndrome: factors in pathogenesis
Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212
Self-citationEvans, R. M., Emsley, C. L., Gao, S., Sahota, A., Hall, K. S., Farlow, M. R., & Hendrie, H. (2000) · Neurology · doi:10.1212/wnl.54.1.240 · Cited by 209
Prevalence of Dementia and Impact on Intellectual Disability Services
Janicki, M. P., & Dalton, A. J. (2000) · Mental Retardation · doi:10.1352/0047-6765(2000)038<0276:podaio>2.0.co;2 · Cited by 195
Genetic and host factors for dementia in Down's syndrome
Schupf, N. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.405 · Cited by 188
Dementia and Alzheimer Disease Incidence Rates Do Not Vary by Sex in Rochester, Minn
Edland, S. D., Rocca, W. A., Petersen, R. C., Cha, R. H., & Kokmen, E. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1589 · Cited by 184
Neuropathology of Organic Brain Syndromes Associated with Aging
Malamud, N. (1972) · Advances in Behavioral Biology · doi:10.1007/978-1-4684-8503-5_6 · Cited by 181
Normal ageing in adults with Down's syndrome: a longitudinal study
Devenny, D. A., Silverman, W. P., Hill, A. L., Jenkins, E., Sersen, E. A., & Wisniewski, K. E. (1996) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1996.tb00624.x · Cited by 171
A four year prospective study of age-related cognitive change in adults with Down's syndrome
OLIVER, C., CRAYTON, L., HOLLAND, A., HALL, S., & BRADBURY, J. (1998) · Psychological Medicine · doi:10.1017/s0033291798007417 · Cited by 171
APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
Romas, S. N., Tang, M.-X., Berglund, L., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.53.3.517 · Cited by 169
THE TOPOGRAPHY OF PLAQUES AND TANGLES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES
MANN, D. M. A., YATES, P. O., MARCYNIUK, B., & RAVINDRA, C. R. (1986) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1986.tb00053.x · Cited by 162
Cholesterol and neuropathologic markers of AD: A population-based autopsy study
Adair, J. C. (2002) · Neurology · doi:10.1212/wnl.59.5.788 · Cited by 152
Furuta, A., Price, D. L., Pardo, C. A., Troncoso, J. C., Xu, Z., Taniguchi, N., & Martin, L. J. (1995) · Europe PMC (PubMed Central) · Cited by 151
Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome
Schupf, N., Patel, B. N., Silverman, W. P., Zigman, W. B., Zhong, N., Tycko, B., Mehta, P. D., & Mayeux, R. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01657-3 · Cited by 148
Self-citationThe Incidence of Mongolism in the General Population
Penrose, L. S. (1949) · Journal of Mental Science · doi:10.1192/bjp.95.400.685 · Cited by 148
Hyman, B. T., West, H. L., Rebeck, G. W., Lai, F., & Mann, D. M. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540280059019 · Cited by 148
Yip, A. G., Brayne, C., & Matthews, F. E. (2006) · Age and Ageing · doi:10.1093/ageing/afj030 · Cited by 144
(1996) · PubMed · Cited by 140
Neuroanatomy of Down Syndrome in vivo: A Model of Preclinical Alzheimer’s Disease
Teipel, S. J., & Hampel, H. J. (2006) · Behavior Genetics · doi:10.1007/s10519-006-9047-x · Cited by 140
Cu/Zn-superoxide dismutase and glutathione peroxidase during aging.
de Haan, J. B., Cristiano, F., Iannello, R. C., & Kola, I. (1995) · PubMed · Cited by 139
Cholesterol and neuropathologic markers of AD: A population-based autopsy study
Launer, L. J., White, L. R., Petrovitch, H., Ross, G. W., & Curb, J. D. (2001) · Neurology · doi:10.1212/wnl.57.8.1447 · Cited by 139
Nistor, M., Don, M., Parekh, M., Sarsoza, F. M., Goodus, M. T., López, G., Kawas, C. H., Leverenz, J. B., Doran, E. W., Lott, I. T., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.023 · Cited by 137
Self-citationEarly menopause in women with Down's syndrome
Schupf, N., Zigman, W. B., Kapell, D., Lee, J. H., Kline, J. K., & Levin, B. L. (1997) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1997.03838.x · Cited by 135
Self-citationOyama, F., Cairns, N. J., Shimada, H., Oyama, R., Titani, K., & Ihara, Y. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031062.x · Cited by 132
Crawford, D. R., Leahy, K. P., Abramova, N. B., Lan, L., Wang, Y., & Davies, K. J. A. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0109 · Cited by 128
Mechanisms of Disease: DNA repair defects and neurological disease
Subba Rao, K. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0448 · Cited by 121
Beta-Amyloid, Oxidative Stress and Down Syndrome
Lott, I. T., Head, E., Doran, E. W., & Busciglio, J. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025305 · Cited by 112
Self-citationHoward, J. A. (1998) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199806000-00012 · Cited by 112
Earlier onset of Alzheimer's disease in men with Down syndrome
Schupf, N., Kapell, D., Nightingale, B., Rodriguez, A., Tycko, B., & Mayeux, R. P. (1998) · Neurology · doi:10.1212/wnl.50.4.991 · Cited by 111
Dermatological manifestations of Down's syndrome
Madan, V., Williams, J. D. L., & Lear, J. T. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02164.x · Cited by 110
Onset of dementia is associated with age at menopause in women with Down's syndrome
Schupf, N., Pang, D. I., Patel, B. N., Silverman, W. P., Schubert, R., Lai, F., Kline, J. K., Stern, Y., Ferin, M., Tycko, B., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10677 · Cited by 108
Bar-Peled, O., Korkotian, E., Segal, M., & Groner, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8530 · Cited by 107
APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
Lai, F., Kammann, Η., Rebeck, G. W., Anderson, A. J., Chen, Y., & Nixon, R. A. (1999) · Neurology · doi:10.1212/wnl.53.2.331 · Cited by 105
Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.
Wolozin, B. L., Scicutella, A., & Davies, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.6202 · Cited by 104
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome
Schupf, N., Kapell, D., Lee, J. H., Schupf, N., Ottman, R., Mayeux, R. P., Lee, J. H., Ottman, R., Ottman, R., & Mayeux, R. P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91398-6 · Cited by 104
Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment
Assini, A., Cammarata, S., Vitali, A., Colucci, M. E. W., Giliberto, L., Borghi, R., Inglese, M. L., Volpe, S., Ratto, S., Dagna-Bricarelli, F., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000137040.64252.ed · Cited by 104
Elevated Plasma β-Amyloid Peptide Aβ42 Levels, Incident Dementia, and Mortality in Down Syndrome
Schupf, N., Patel, B. N., Pang, D. I., Zigman, W. B., Silverman, W. P., Mehta, P. D., & Mayeux, R. P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.1007 · Cited by 103
Self-citationKalmuc Idiocy: Report of a Case with Autopsy
Fraser, J., & Mitchell, A. (1876) · Journal of Mental Science · doi:10.1192/bjp.22.98.169 · Cited by 101
Royston, M. C., Mann, D. M. A., Pickering-Brown, S. M., Owen, F., Perry, R., Raghavan, R., Khin-IMu, C., Tyrer, S. P., Day, K. A., Crook, R., et al. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00044 · Cited by 94
Onset of dementia is associated with apolipoprotein E ε4 in Down's syndrome
Schupf, N., Lee, J. H., Kapell, D., Zigman, W. B., Canto, B., Tycko, B., & Mayeux, R. P. (1996) · Annals of Neurology · doi:10.1002/ana.410400518 · Cited by 92
Self-citationFundamentals of Genetic Epidemiology
Bishop, D. T. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.11.900 · Cited by 92
Head, E., Lott, I. T., Patterson, D. W., Doran, E. W., & Haier, R. J. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11110 · Cited by 91
Self-citationDelacourte, A., Défossez, A., Ceballos-Picot, I., Nicole, A., & Sinet, P. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90597-6 · Cited by 89
Discrepancy between Alzheimer‐Type Neuropathology and Dementia in Persons with Down's Syndromea
Wísniewski, H. M., & Rabe, A. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb40344.x · Cited by 81
A prospective study of menopause in women with Down's syndrome
Seltzer, G. B., Schupf, N., & Wu, H.-S. (2001) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2001.00286.x · Cited by 81
Histopathologische Untersuchungen über Entstehung und Wesen der senilen Plaques
Struwe, F. E. (1929) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02876635 · Cited by 79
Badwey, J. A., Curnutte, J. T., Robinson, J. M., Lazdins, J. K., Briggs, R. T., Karnovsky, M. J., & Karnovsky, M. J. (1980) · Journal of Cellular Physiology · doi:10.1002/jcp.1041050319 · Cited by 77
Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia
Jenkins, E. C., Velinov, M. T., Ye, L., Gu, H., Li, S., Jenkins, E. C., Brooks, S. S., Pang, D. I., Devenny, D. A., Zigman, W. B., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.021 · Cited by 77
Self-citationComparative survival advantage of males with down syndrome
Glasson, E. J., Sullivan, S. G., Hussain, R., Petterson, B., Montgomery, P., & Bittles, A. H. (2003) · American Journal of Human Biology · doi:10.1002/ajhb.10132 · Cited by 75
Bo, R. D., Comi, G. P., Bresolin, N., Castelli, E., Conti, E., Degiuli, A., Ausenda, C. D., & Scarlato, G. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00249-3 · Cited by 75
Incidence and Temporal Patterns of Adaptive Behavior Change in Adults With Mental Retardation
Zigman, W. B., Schupf, N., Urv, T. K., Zigman, A., & Silverman, W. P. (2002) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2002)107<0161:iatpoa>2.0.co;2 · Cited by 74
Self-citationAPOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
Deb, S., Braganza, J., Norton, N., Williams, H., Kehoe, P. G., Williams, J., & Owen, M. J. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.5.468 · Cited by 71
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
Haier, R. J., Alkire, M. T., White, N. S., Uncapher, M. R., Head, E., Lott, I. T., & Cotman, C. W. (2003) · Neurology · doi:10.1212/01.wnl.0000098935.36984.25 · Cited by 71
Self-citationAge at onset of dementia and age of menopause in women with Down’s syndrome
Cosgrave, M., Tyrrell, J., McCarron, M., Gill, M., & LAWLOR, B. A. (1999) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.1999.00192.x · Cited by 71
Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein
Lin, H., Michtalik, H. J., Zhang, S., Andersen, T. T., Riper, D. A. V., Davies, K. J. A., Ermak, G., Petti, L. M., Nachod, S., Narayan, A., et al. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00358-7 · Cited by 71
Neurological changes and emotional functioning in adults with Down Syndrome
Nelson, L. D., Orme, D., Osann, K., & Lott, I. T. (2001) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.2001.00379.x · Cited by 71
Self-citationZigman, W. B., Schupf, N., Haveman, M. J., & Silverman, W. P. (1997) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1997.tb00679.x · Cited by 71
Self-citationDown's Syndrome in Adults: Brain Metabolism
Schwartz, M. L., Duara, R., Haxby, J. V., Grady, C., White, B. J., KESSLER, R. M., Kay, A. D., Cutler, N. R., & Рапопорт, С. И. (1983) · Science · doi:10.1126/science.6224294 · Cited by 70
de Andrade, F. M., Larrandaburu, M., Callegari-Jacques, S. M., Gastaldo, G. J., & Hutz, M. H. (2000) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2000000500007 · Cited by 69
Goldgaber, D., Lerman, M. I., McBride, W. O., Saffiotti, U., & Gajdusek, D. C. (1987) · PubMed · Cited by 67
Schupf, N., Winsten, S., Patel, B. N., Pang, D. I., Ferin, M., Zigman, W. B., Silverman, W. P., & Mayeux, R. P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.062 · Cited by 66
Self-citationElevated sex-hormone binding globulin in elderly women with Alzheimer’s disease
Hoskin, E. K., Tang, M. X., Manly, J. J., & Mayeux, R. P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00046-0 · Cited by 65
Regional Cerebral Glucose Metabolism is Normal in Young Adults with down Syndrome
Schapiro, M. B., Grady, C. L., Kumar, A., Herscovitch, P., Haxby, J. V., Moore, A. M., White, B. J., Friedland, R. P., & Rapoport, S. I. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.35 · Cited by 65
Molecular Dating of Senile Plaques in the Brains of Individuals with Down Syndrome and in Aged Dogs
Azizeh, B. Y., Head, E., Ibrahim, M. A., Torp, R., Tenner, A. J., Kim, R. C., Lott, I. T., & Cotman, C. W. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7359 · Cited by 59
Self-citationPietrini, P., Dani, A., Furey, M. L., Alexander, G. E., Freo, U., Grady, C. L., Mentis, M. J., Mangot, D., Simon, E. W., Horwitz, B., et al. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1063 · Cited by 57
Aging and Alzheimer's disease in Down syndrome: Clinical and pathological changes
Zigman, W. B., Silverman, W. P., & Wísniewski, H. M. (1996) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/(sici)1098-2779(1996)2:2<73::aid-mrdd3>3.0.co;2-y · Cited by 57
Self-citationPrasher, V. P., & Chung, M. C. (1996) · PubMed · Cited by 56
ApoE Genotype and Alzheimer's Disease in Adults With Down Syndrome: Meta-Analysis
Prasher, V. P., Chowdhury, T. A., Rowe, B. R., & Bain, S. C. (1997) · American Journal on Mental Retardation · doi:10.1352/0895-8017(1997)102<0103:agaadi>2.0.co;2 · Cited by 53
Mortality and survival for Down syndrome in Japan.
Masaki, M., Higurashi, M., Iijima, K., Ishikawa, N., Tanaka, F., Fujii, T., Kuroki, Y., Matsui, I., IINUMA, K., Matsuo, N., et al. (1981) · Europe PMC (PubMed Central) · Cited by 53
Alzheimer's Disease and Maternal Age
Cohén, D., Eisdorfer, C., & Leverenz, J. B. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb05065.x · Cited by 51
The Relationship between Apolipoprotein E4 and Lipid Metabolism Is Impaired in Alzheimer’s Disease
Dupuy, A., Mas, E., Ritchie, K. A., Descomps, B., Badiou, S., Cristol, J., & Touchon, J. (2001) · Gerontology · doi:10.1159/000052801 · Cited by 50
Cholesterol level, statin use and Alzheimer's disease in adults with Down syndrome
Zigman, W. B., Schupf, N., Jenkins, E. C., Urv, T. K., Tycko, B., & Silverman, W. P. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.023 · Cited by 48
Self-citationAging and Alzheimer Disease in People with Mental Retardation
Zigman, W. B., Schupf, N., Zigman, A., & Silverman, W. P. (1993) · International review of research in mental retardation · doi:10.1016/s0074-7750(08)60188-3 · Cited by 46
Self-citationLambert, J., Mann, D. M. A., Goumidi, L., Harris, J., Amouyel, P., Iwatsubo, T., Lendon, C., & Chartier‐Harlin, M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04063-0 · Cited by 46
Stress, Aging, and Neurodegenerative Disorders: Molecular Mechanismsa
Busciglio, J. A., Andersen, J. K., Schipper, H. M., Gilad, G. M., McCarty, R. C., Marzatico, F., & Toussaint, O. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09021.x · Cited by 45
Prevalence of dementia in adult patients with trisomy 21
Franceschi, M., Comola, M., Piattoni, F., Gualandri, W., & Canal, N. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370760 · Cited by 44
Sohn, Y. K., Ganju, N., Bloch, K. D., Wands, J. R., & de la Monte, S. M. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00297-4 · Cited by 44
Evidence for increased mitochondrial superoxide production in Down syndrome
Capone, G. T., Kim, P., Jovanovich, S., Payne, L., Freund, L. S., Welch, K., Miller, E. M., & Trush, M. A. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01538-2 · Cited by 44
Schapiro, M. B., Ball, M. J., Grady, C. L., Haxby, J. V., Kaye, J. A., & Рапопорт, С. И. (1988) · Neurology · doi:10.1212/wnl.38.6.938 · Cited by 43
Risk factors and early signs of Alzheimer's disease in a family study sample: Risk of AD
Heun, R., Kölsch, H., & Jessen, F. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0596-4 · Cited by 42
Cutler, N. R. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90010-2 · Cited by 41
Brooksbank, B. W. L., Martínez, M., & Balázs, R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb12896.x · Cited by 41
Cytotoxic effects of expression of human superoxide dismutase in bovine adrenocortical cells
Norris, K. H., & Hornsby, P. J. (1990) · Mutation Research/DNAging · doi:10.1016/0921-8734(90)90015-j · Cited by 40
Farrer, L. A., Cupples, L. A., Connor, L., Wolf, P. A., & Growdon, J. H. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530180051017 · Cited by 40
Head, E., Lott, I. T., Hof, P. R., Bouras, C., Su, J., Kim, R., Haier, R. J., & Cotman, C. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.917 · Cited by 38
Self-citationApolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia
Wehr, H., Parnowski, T., Puźyński, S., Bednarska‐Makaruk, M., Bisko, M., Kotapka-Minc, S., RODO, M., & Wołkowska, M. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017217 · Cited by 37
Hoshino, T., Kamino, K., & Matsumoto, M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00252-4 · Cited by 35
DSCR1(Adapl78) modulates expression of SOD1
Ermak, G., Cheadle, C., Becker, K. G., Harris, C. D., & Davies, K. J. A. (2004) · The FASEB Journal · doi:10.1096/fj.03-0451com · Cited by 35
Apolopoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease
İşbir, T., Ağaçhan, B., Yılmaz, H., Aydın, M., Kara, İ., Eker, E., & Eker, D. (2001) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750101600207 · Cited by 33
Apo E genotypes and risk of dementia in Down syndrome
Rubinsztein, D. C., Hon, J., Stevens, F., Pyrah, I. T. G., Tysoe, C. J., Huppert, F. A., Easton, D. F., & Holland, A. J. (1999) · American Journal of Medical Genetics · Cited by 33
Obesity enhances verbal memory in postmenopausal women with Down syndrome
Patel, B. N., Pang, D. I., Stern, Y., Silverman, W. P., Kline, J. K., Mayeux, R. P., & Schupf, N. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00089-7 · Cited by 31
Mortality is associated with apolipoprotein E ɛ4 in nondemented adults with Down syndrome
Zigman, W. B., Jenkins, E. C., Tycko, B., Schupf, N., & Silverman, W. P. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.002 · Cited by 31
Self-citationAlternative Pathways Might Mediate Toxicity of High Concentrations of Superoxide Dismutase
Kowald, A., & Klipp, E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.065 · Cited by 31
Yarom, R., Sherman, Y., Sagher, U., et al. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90238-3 · Cited by 30
Comorbidity in people with Down's syndrome: a criteria‐based analysis
Valk, H. M. J. V. S. L., Haveman, M. J., & Crebolder, H. F. J. M. (1996) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.1996.tb00646.x · Cited by 30
The Prevalence of Dementia in Down Syndrome
Johannsen, P., Christensen, J. E. J., & Mai, J. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106883 · Cited by 30
Brain cognition and metabolism in Down syndrome adults in association with development of dementia
Dani, A., Pietrini, P., Furey, M. L., et al. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00026 · Cited by 30
Erythrocyte antioxidant system in Down syndrome
Gerli, G., Zenoni, L., Locatelli, G. F., Mongiat, R., Piattoni, F., Orsini, G. B., Montagnani, A., Gueli, M. R., & Gualandri, V. (2005) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320370754 · Cited by 26
Free radical damage in Down's syndrome brain
Reynolds, G. P., & CUTTS, A. J. (1993) · Biochemical Society Transactions · doi:10.1042/bst021221s · Cited by 17
Schoenberg, B. S. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30981-2 · Cited by 15
Greber‐Platzer, S., Fleischmann, C., Nussbaumer, C., Cairns, N. J., & Lübec, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01150-3 · Cited by 10
On the occurrence of neuronal sprouting in the frontal cortex of a patient with Down's syndrome
Ohara, S., Tsukada, M., & Ikeda, S.-I. (1999) · Acta Neuropathologica · doi:10.1007/s004010050959 · Cited by 7
Rocca, W. A. (1987) · PubMed · Cited by 5
Abbeduto (2004) · doi:10.1352/0895-8017(2004)109
Cited by
Health Supervision for Children With Down Syndrome
Bull, M. J., & the Committee on Genetics (2011) · Pediatrics · doi:10.1542/peds.2011-1605 · Cited by 1,231
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484
Self-citationTargeting protein aggregation for the treatment of degenerative diseases
Eisele, Y. S., Monteiro, C., Fearns, C., Encalada, S. E., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4593 · Cited by 419
Language Characteristics of Individuals With Down Syndrome
Martin, G. E., Klusek, J., Estigarribia, B., & Roberts, J. E. (2009) · Topics in Language Disorders · doi:10.1097/tld.0b013e3181a71fe1 · Cited by 399
Down syndrome: Cognitive and behavioral functioning across the lifespan
Grieco, J., Pulsifer, M., Seligsohn, K., Skotko, B., & Schwartz, A. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31439 · Cited by 377
Metadata
- Authors
- Zigman, W. B., & Lott, I. T.
- Venue
- Mental Retardation and Developmental Disabilities Research Reviews
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 13
- Issue
- 3
- Pages
- 237-246
- ISSN
- 1080-4013 (ISSN-L)
- 1098-2779
- OpenAlex
- W2165462380
- Cited by
- 278
- References
- 164
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.